QHSLab, Inc. Files 8-K Report
Ticker: USAQ · Form: 8-K · Filed: Jun 3, 2025 · CIK: 856984
Sentiment: neutral
Topics: disclosure, financials, corporate-action
TL;DR
QHSLab filed an 8-K for Reg FD and financials. Nothing major, just housekeeping.
AI Summary
On June 3, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and its fiscal year ends on December 31st.
Why It Matters
This 8-K filing indicates routine corporate disclosures and the submission of financial statements, providing transparency to investors about the company's regulatory compliance and financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, not indicating any immediate significant events or changes.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- USA EQUITIES CORP. (company) — Former Company Name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former Company Name
- June 3, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for QHSLab, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 3, 2025.
In which state is QHSLab, Inc. incorporated?
QHSLab, Inc. is incorporated in Nevada.
What is the business address of QHSLab, Inc.?
The business address of QHSLab, Inc. is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.
What were some of the former names of QHSLab, Inc.?
Some of the former names of QHSLab, Inc. include USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding QHSLab, Inc. (USAQ).